Why the study?
To report the first cases of transapical off-pump NeoChord procedure in patients with mitral valve prolapse in mainland China.
Is the transapical off-pump NeoChord procedure feasible and safe for treating severe degenerative mitral regurgitation in Chinese patients?
Is the transapical off-pump NeoChord procedure feasible and safe for treating severe degenerative mitral regurgitation in Chinese patients?
The transapical off-pump NeoChord procedure is feasible and safe for treating severe degenerative mitral regurgitation in the Chinese population.
No takes yet. Share an insight, caveat, or question.
Demonstrates feasibility of NeoChord in mainland China; leaves open long-term outcomes before clinical adoption.
Wang et al. (2019) studied this question.